Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease
Identifieur interne :
002C75 ( PascalFrancis/Corpus );
précédent :
002C74;
suivant :
002C76
Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease
Auteurs : S. A. Factor ;
D. L. Brown ;
E. S. MolhoSource :
-
Movement disorders [ 0885-3185 ] ; 2000.
RBID : Pascal:00-0065618
Descripteurs français
- Pascal (Inist)
- Parkinson maladie,
Douleur,
Réfractaire,
Effet off,
Apomorphine,
Voie souscutanée,
Agoniste,
Récepteur dopaminergique,
Stimulant dopaminergique,
Injection bolus,
Analgésique,
Etude cas,
Traitement,
Complication,
Personne âgée,
Femelle.
English descriptors
- KwdEn :
- Agonist,
Analgesic,
Bolus injection,
Case study,
Complication,
Dopamine agonist,
Dopamine receptor,
Elderly,
Female,
Off effect,
Pain,
Parkinson disease,
Refractory,
Subcutaneous administration,
Treatment.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
| pA |
| A01 | 01 | 1 | | @0 0885-3185 |
|---|
| A03 | | 1 | | @0 Mov. disord. |
|---|
| A05 | | | | @2 15 |
|---|
| A06 | | | | @2 1 |
|---|
| A08 | 01 | 1 | ENG | @1 Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease |
|---|
| A11 | 01 | 1 | | @1 FACTOR (S. A.) |
|---|
| A11 | 02 | 1 | | @1 BROWN (D. L.) |
|---|
| A11 | 03 | 1 | | @1 MOLHO (E. S.) |
|---|
| A14 | 01 | | | @1 Albany Medical College, Department of Neurology @2 Albany, New York @3 USA @Z 1 aut. @Z 2 aut. @Z 3 aut. |
|---|
| A20 | | | | @1 167-169 |
|---|
| A21 | | | | @1 2000 |
|---|
| A23 | 01 | | | @0 ENG |
|---|
| A43 | 01 | | | @1 INIST @2 20953 @5 354000081097210270 |
|---|
| A44 | | | | @0 0000 @1 © 2000 INIST-CNRS. All rights reserved. |
|---|
| A45 | | | | @0 13 ref. |
|---|
| A47 | 01 | 1 | | @0 00-0065618 |
|---|
| A60 | | | | @1 P |
|---|
| A61 | | | | @0 A |
|---|
| A64 | 01 | 1 | | @0 Movement disorders |
|---|
| A66 | 01 | | | @0 USA |
|---|
| C02 | 01 | X | | @0 002B02B05 |
|---|
| C03 | 01 | X | FRE | @0 Parkinson maladie @5 01 |
|---|
| C03 | 01 | X | ENG | @0 Parkinson disease @5 01 |
|---|
| C03 | 01 | X | SPA | @0 Parkinson enfermedad @5 01 |
|---|
| C03 | 02 | X | FRE | @0 Douleur @5 04 |
|---|
| C03 | 02 | X | ENG | @0 Pain @5 04 |
|---|
| C03 | 02 | X | SPA | @0 Dolor @5 04 |
|---|
| C03 | 03 | X | FRE | @0 Réfractaire @5 05 |
|---|
| C03 | 03 | X | ENG | @0 Refractory @5 05 |
|---|
| C03 | 03 | X | SPA | @0 Refractario @5 05 |
|---|
| C03 | 04 | X | FRE | @0 Effet off @5 06 |
|---|
| C03 | 04 | X | ENG | @0 Off effect @5 06 |
|---|
| C03 | 04 | X | SPA | @0 Efecto apagado @5 06 |
|---|
| C03 | 05 | X | FRE | @0 Apomorphine @2 NK @2 FR @5 07 |
|---|
| C03 | 06 | X | FRE | @0 Voie souscutanée @5 08 |
|---|
| C03 | 06 | X | ENG | @0 Subcutaneous administration @5 08 |
|---|
| C03 | 06 | X | SPA | @0 Vía subcutánea @5 08 |
|---|
| C03 | 07 | X | FRE | @0 Agoniste @5 09 |
|---|
| C03 | 07 | X | ENG | @0 Agonist @5 09 |
|---|
| C03 | 07 | X | SPA | @0 Agonista @5 09 |
|---|
| C03 | 08 | X | FRE | @0 Récepteur dopaminergique @5 10 |
|---|
| C03 | 08 | X | ENG | @0 Dopamine receptor @5 10 |
|---|
| C03 | 08 | X | SPA | @0 Receptor dopaminérgico @5 10 |
|---|
| C03 | 09 | X | FRE | @0 Stimulant dopaminergique @5 11 |
|---|
| C03 | 09 | X | ENG | @0 Dopamine agonist @5 11 |
|---|
| C03 | 09 | X | SPA | @0 Estimulante dopaminérgico @5 11 |
|---|
| C03 | 10 | X | FRE | @0 Injection bolus @5 12 |
|---|
| C03 | 10 | X | ENG | @0 Bolus injection @5 12 |
|---|
| C03 | 10 | X | SPA | @0 Inyección bolo @5 12 |
|---|
| C03 | 11 | X | FRE | @0 Analgésique @5 13 |
|---|
| C03 | 11 | X | ENG | @0 Analgesic @5 13 |
|---|
| C03 | 11 | X | SPA | @0 Analgésico @5 13 |
|---|
| C03 | 12 | X | FRE | @0 Etude cas @5 17 |
|---|
| C03 | 12 | X | ENG | @0 Case study @5 17 |
|---|
| C03 | 12 | X | SPA | @0 Estudio caso @5 17 |
|---|
| C03 | 13 | X | FRE | @0 Traitement @5 18 |
|---|
| C03 | 13 | X | ENG | @0 Treatment @5 18 |
|---|
| C03 | 13 | X | SPA | @0 Tratamiento @5 18 |
|---|
| C03 | 14 | X | FRE | @0 Complication @5 19 |
|---|
| C03 | 14 | X | ENG | @0 Complication @5 19 |
|---|
| C03 | 14 | X | SPA | @0 Complicación @5 19 |
|---|
| C03 | 15 | X | FRE | @0 Personne âgée @5 20 |
|---|
| C03 | 15 | X | ENG | @0 Elderly @5 20 |
|---|
| C03 | 15 | X | SPA | @0 Anciano @5 20 |
|---|
| C03 | 16 | X | FRE | @0 Femelle @5 21 |
|---|
| C03 | 16 | X | ENG | @0 Female @5 21 |
|---|
| C03 | 16 | X | SPA | @0 Hembra @5 21 |
|---|
| C07 | 01 | X | FRE | @0 Homme |
|---|
| C07 | 01 | X | ENG | @0 Human |
|---|
| C07 | 01 | X | SPA | @0 Hombre |
|---|
| C07 | 02 | X | FRE | @0 Système nerveux pathologie @5 37 |
|---|
| C07 | 02 | X | ENG | @0 Nervous system diseases @5 37 |
|---|
| C07 | 02 | X | SPA | @0 Sistema nervioso patología @5 37 |
|---|
| C07 | 03 | X | FRE | @0 Système nerveux central pathologie @5 38 |
|---|
| C07 | 03 | X | ENG | @0 Central nervous system disease @5 38 |
|---|
| C07 | 03 | X | SPA | @0 Sistema nervosio central patología @5 38 |
|---|
| C07 | 04 | X | FRE | @0 Encéphale pathologie @5 39 |
|---|
| C07 | 04 | X | ENG | @0 Cerebral disorder @5 39 |
|---|
| C07 | 04 | X | SPA | @0 Encéfalo patología @5 39 |
|---|
| C07 | 05 | X | FRE | @0 Extrapyramidal syndrome @5 40 |
|---|
| C07 | 05 | X | ENG | @0 Extrapyramidal syndrome @5 40 |
|---|
| C07 | 05 | X | SPA | @0 Extrapiramidal síndrome @5 40 |
|---|
| C07 | 06 | X | FRE | @0 Maladie dégénérative @5 41 |
|---|
| C07 | 06 | X | ENG | @0 Degenerative disease @5 41 |
|---|
| C07 | 06 | X | SPA | @0 Enfermedad degenerativa @5 41 |
|---|
| N21 | | | | @1 045 |
|---|
|
|---|
Format Inist (serveur)
| NO : | PASCAL 00-0065618 INIST |
|---|
| ET : | Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease |
|---|
| AU : | FACTOR (S. A.); BROWN (D. L.); MOLHO (E. S.) |
|---|
| AF : | Albany Medical College, Department of Neurology/Albany, New York/Etats-Unis (1 aut., 2 aut., 3 aut.) |
|---|
| DT : | Publication en série; Niveau analytique |
|---|
| SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2000; Vol. 15; No. 1; Pp. 167-169; Bibl. 13 ref. |
|---|
| LA : | Anglais |
|---|
| CC : | 002B02B05 |
|---|
| FD : | Parkinson maladie; Douleur; Réfractaire; Effet off; Apomorphine; Voie souscutanée; Agoniste; Récepteur dopaminergique; Stimulant dopaminergique; Injection bolus; Analgésique; Etude cas; Traitement; Complication; Personne âgée; Femelle |
|---|
| FG : | Homme; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative |
|---|
| ED : | Parkinson disease; Pain; Refractory; Off effect; Subcutaneous administration; Agonist; Dopamine receptor; Dopamine agonist; Bolus injection; Analgesic; Case study; Treatment; Complication; Elderly; Female |
|---|
| EG : | Human; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease |
|---|
| SD : | Parkinson enfermedad; Dolor; Refractario; Efecto apagado; Vía subcutánea; Agonista; Receptor dopaminérgico; Estimulante dopaminérgico; Inyección bolo; Analgésico; Estudio caso; Tratamiento; Complicación; Anciano; Hembra |
|---|
| LO : | INIST-20953.354000081097210270 |
|---|
| ID : | 00-0065618 |
|---|
Links to Exploration step
Pascal:00-0065618
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease</title>
<author><name sortKey="Factor, S A" sort="Factor, S A" uniqKey="Factor S" first="S. A." last="Factor">S. A. Factor</name>
<affiliation><inist:fA14 i1="01"><s1>Albany Medical College, Department of Neurology</s1>
<s2>Albany, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14><author><name sortKey="Brown, D L" sort="Brown, D L" uniqKey="Brown D" first="D. L." last="Brown">D. L. Brown</name>
<affiliation><inist:fA14 i1="01"><s1>Albany Medical College, Department of Neurology</s1>
<s2>Albany, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14><author><name sortKey="Molho, E S" sort="Molho, E S" uniqKey="Molho E" first="E. S." last="Molho">E. S. Molho</name>
<affiliation><inist:fA14 i1="01"><s1>Albany Medical College, Department of Neurology</s1>
<s2>Albany, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14><publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">00-0065618</idno>
<date when="2000">2000</date>
<idno type="stanalyst">PASCAL 00-0065618 INIST</idno>
<idno type="RBID">Pascal:00-0065618</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002C75</idno>
</publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease</title>
<author><name sortKey="Factor, S A" sort="Factor, S A" uniqKey="Factor S" first="S. A." last="Factor">S. A. Factor</name>
<affiliation><inist:fA14 i1="01"><s1>Albany Medical College, Department of Neurology</s1>
<s2>Albany, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14><author><name sortKey="Brown, D L" sort="Brown, D L" uniqKey="Brown D" first="D. L." last="Brown">D. L. Brown</name>
<affiliation><inist:fA14 i1="01"><s1>Albany Medical College, Department of Neurology</s1>
<s2>Albany, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14><author><name sortKey="Molho, E S" sort="Molho, E S" uniqKey="Molho E" first="E. S." last="Molho">E. S. Molho</name>
<affiliation><inist:fA14 i1="01"><s1>Albany Medical College, Department of Neurology</s1>
<s2>Albany, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14><series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2000">2000</date>
</imprint><seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Agonist</term>
<term>Analgesic</term>
<term>Bolus injection</term>
<term>Case study</term>
<term>Complication</term>
<term>Dopamine agonist</term>
<term>Dopamine receptor</term>
<term>Elderly</term>
<term>Female</term>
<term>Off effect</term>
<term>Pain</term>
<term>Parkinson disease</term>
<term>Refractory</term>
<term>Subcutaneous administration</term>
<term>Treatment</term>
</keywords><keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Douleur</term>
<term>Réfractaire</term>
<term>Effet off</term>
<term>Apomorphine</term>
<term>Voie souscutanée</term>
<term>Agoniste</term>
<term>Récepteur dopaminergique</term>
<term>Stimulant dopaminergique</term>
<term>Injection bolus</term>
<term>Analgésique</term>
<term>Etude cas</term>
<term>Traitement</term>
<term>Complication</term>
<term>Personne âgée</term>
<term>Femelle</term>
</keywords><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01><fA03 i2="1"><s0>Mov. disord.</s0>
</fA03><fA08 i1="01" i2="1" l="ENG"><s1>Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease</s1>
</fA08><fA11 i1="01" i2="1"><s1>FACTOR (S. A.)</s1>
</fA11><fA11 i1="02" i2="1"><s1>BROWN (D. L.)</s1>
</fA11><fA11 i1="03" i2="1"><s1>MOLHO (E. S.)</s1>
</fA11><fA14 i1="01"><s1>Albany Medical College, Department of Neurology</s1>
<s2>Albany, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14><fA20><s1>167-169</s1>
</fA20><fA21><s1>2000</s1>
</fA21><fA23 i1="01"><s0>ENG</s0>
</fA23><fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000081097210270</s5>
</fA43><fA44><s0>0000</s0>
<s1>© 2000 INIST-CNRS. All rights reserved.</s1>
</fA44><fA45><s0>13 ref.</s0>
</fA45><fA47 i1="01" i2="1"><s0>00-0065618</s0>
</fA47><fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64><fA66 i1="01"><s0>USA</s0>
</fA66><fC02 i1="01" i2="X"><s0>002B02B05</s0>
</fC02><fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03><fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03><fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03><fC03 i1="02" i2="X" l="FRE"><s0>Douleur</s0>
<s5>04</s5>
</fC03><fC03 i1="02" i2="X" l="ENG"><s0>Pain</s0>
<s5>04</s5>
</fC03><fC03 i1="02" i2="X" l="SPA"><s0>Dolor</s0>
<s5>04</s5>
</fC03><fC03 i1="03" i2="X" l="FRE"><s0>Réfractaire</s0>
<s5>05</s5>
</fC03><fC03 i1="03" i2="X" l="ENG"><s0>Refractory</s0>
<s5>05</s5>
</fC03><fC03 i1="03" i2="X" l="SPA"><s0>Refractario</s0>
<s5>05</s5>
</fC03><fC03 i1="04" i2="X" l="FRE"><s0>Effet off</s0>
<s5>06</s5>
</fC03><fC03 i1="04" i2="X" l="ENG"><s0>Off effect</s0>
<s5>06</s5>
</fC03><fC03 i1="04" i2="X" l="SPA"><s0>Efecto apagado</s0>
<s5>06</s5>
</fC03><fC03 i1="05" i2="X" l="FRE"><s0>Apomorphine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03><fC03 i1="06" i2="X" l="FRE"><s0>Voie souscutanée</s0>
<s5>08</s5>
</fC03><fC03 i1="06" i2="X" l="ENG"><s0>Subcutaneous administration</s0>
<s5>08</s5>
</fC03><fC03 i1="06" i2="X" l="SPA"><s0>Vía subcutánea</s0>
<s5>08</s5>
</fC03><fC03 i1="07" i2="X" l="FRE"><s0>Agoniste</s0>
<s5>09</s5>
</fC03><fC03 i1="07" i2="X" l="ENG"><s0>Agonist</s0>
<s5>09</s5>
</fC03><fC03 i1="07" i2="X" l="SPA"><s0>Agonista</s0>
<s5>09</s5>
</fC03><fC03 i1="08" i2="X" l="FRE"><s0>Récepteur dopaminergique</s0>
<s5>10</s5>
</fC03><fC03 i1="08" i2="X" l="ENG"><s0>Dopamine receptor</s0>
<s5>10</s5>
</fC03><fC03 i1="08" i2="X" l="SPA"><s0>Receptor dopaminérgico</s0>
<s5>10</s5>
</fC03><fC03 i1="09" i2="X" l="FRE"><s0>Stimulant dopaminergique</s0>
<s5>11</s5>
</fC03><fC03 i1="09" i2="X" l="ENG"><s0>Dopamine agonist</s0>
<s5>11</s5>
</fC03><fC03 i1="09" i2="X" l="SPA"><s0>Estimulante dopaminérgico</s0>
<s5>11</s5>
</fC03><fC03 i1="10" i2="X" l="FRE"><s0>Injection bolus</s0>
<s5>12</s5>
</fC03><fC03 i1="10" i2="X" l="ENG"><s0>Bolus injection</s0>
<s5>12</s5>
</fC03><fC03 i1="10" i2="X" l="SPA"><s0>Inyección bolo</s0>
<s5>12</s5>
</fC03><fC03 i1="11" i2="X" l="FRE"><s0>Analgésique</s0>
<s5>13</s5>
</fC03><fC03 i1="11" i2="X" l="ENG"><s0>Analgesic</s0>
<s5>13</s5>
</fC03><fC03 i1="11" i2="X" l="SPA"><s0>Analgésico</s0>
<s5>13</s5>
</fC03><fC03 i1="12" i2="X" l="FRE"><s0>Etude cas</s0>
<s5>17</s5>
</fC03><fC03 i1="12" i2="X" l="ENG"><s0>Case study</s0>
<s5>17</s5>
</fC03><fC03 i1="12" i2="X" l="SPA"><s0>Estudio caso</s0>
<s5>17</s5>
</fC03><fC03 i1="13" i2="X" l="FRE"><s0>Traitement</s0>
<s5>18</s5>
</fC03><fC03 i1="13" i2="X" l="ENG"><s0>Treatment</s0>
<s5>18</s5>
</fC03><fC03 i1="13" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>18</s5>
</fC03><fC03 i1="14" i2="X" l="FRE"><s0>Complication</s0>
<s5>19</s5>
</fC03><fC03 i1="14" i2="X" l="ENG"><s0>Complication</s0>
<s5>19</s5>
</fC03><fC03 i1="14" i2="X" l="SPA"><s0>Complicación</s0>
<s5>19</s5>
</fC03><fC03 i1="15" i2="X" l="FRE"><s0>Personne âgée</s0>
<s5>20</s5>
</fC03><fC03 i1="15" i2="X" l="ENG"><s0>Elderly</s0>
<s5>20</s5>
</fC03><fC03 i1="15" i2="X" l="SPA"><s0>Anciano</s0>
<s5>20</s5>
</fC03><fC03 i1="16" i2="X" l="FRE"><s0>Femelle</s0>
<s5>21</s5>
</fC03><fC03 i1="16" i2="X" l="ENG"><s0>Female</s0>
<s5>21</s5>
</fC03><fC03 i1="16" i2="X" l="SPA"><s0>Hembra</s0>
<s5>21</s5>
</fC03><fC07 i1="01" i2="X" l="FRE"><s0>Homme</s0>
</fC07><fC07 i1="01" i2="X" l="ENG"><s0>Human</s0>
</fC07><fC07 i1="01" i2="X" l="SPA"><s0>Hombre</s0>
</fC07><fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07><fC07 i1="02" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07><fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07><fC07 i1="03" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07><fC07 i1="03" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07><fC07 i1="03" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07><fC07 i1="04" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07><fC07 i1="04" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07><fC07 i1="04" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07><fC07 i1="05" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07><fC07 i1="05" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07><fC07 i1="05" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07><fC07 i1="06" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07><fC07 i1="06" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07><fC07 i1="06" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07><fN21><s1>045</s1>
</fN21><server><NO>PASCAL 00-0065618 INIST</NO>
<ET>Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease</ET>
<AU>FACTOR (S. A.); BROWN (D. L.); MOLHO (E. S.)</AU>
<AF>Albany Medical College, Department of Neurology/Albany, New York/Etats-Unis (1 aut., 2 aut., 3 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2000; Vol. 15; No. 1; Pp. 167-169; Bibl. 13 ref.</SO>
<LA>Anglais</LA>
<CC>002B02B05</CC>
<FD>Parkinson maladie; Douleur; Réfractaire; Effet off; Apomorphine; Voie souscutanée; Agoniste; Récepteur dopaminergique; Stimulant dopaminergique; Injection bolus; Analgésique; Etude cas; Traitement; Complication; Personne âgée; Femelle</FD>
<FG>Homme; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative</FG>
<ED>Parkinson disease; Pain; Refractory; Off effect; Subcutaneous administration; Agonist; Dopamine receptor; Dopamine agonist; Bolus injection; Analgesic; Case study; Treatment; Complication; Elderly; Female</ED>
<EG>Human; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease</EG>
<SD>Parkinson enfermedad; Dolor; Refractario; Efecto apagado; Vía subcutánea; Agonista; Receptor dopaminérgico; Estimulante dopaminérgico; Inyección bolo; Analgésico; Estudio caso; Tratamiento; Complicación; Anciano; Hembra</SD>
<LO>INIST-20953.354000081097210270</LO>
<ID>00-0065618</ID>
</server>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C75 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 002C75 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:00-0065618
|texte= Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
